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Purpose: This study was performed to test the effectiveness of a formal supervised exercise 
program against a home-based exercise program for both walking ability and quality of  
life endpoints. 
Methods: Patients with arterial claudication were randomized to either a 12-week super- 
vised exercise program (SUPEX) with weekly lectures relating to peripheral vascular 
disease or to a home exercise group (HOMEX) who attended an identical lecture 
program and received weekly exercise instruction. The study population included 29 men 
and 26 women, with a mean age of 69.1 - 8.1 years. Forty-seven patients completed the 
12-week program, 46 were available for testing at completion, and 38 for 6-month 
testing. Claudication pain time (CPT) and maximum walking time (MWT) on a progres- 
sive treadmill exercise test were assessed at baseline, program completion, and 6 months. 
The Medical Outcomes Study Short Form-36 (SF-36) was administered at these intervals 
to assess effects on quality of  life. 
Results: Each group improved (p < 0.001) in both CPT and MWT at the completion of  
the 12-week program, which was sustained at the 6-month follow-up. Increase in 
HOMEX CPT from baseline (3.6 -+ 2.73 minutes) to 6-month follow-up (6.6 -+ 3.17 
minutes) was less than for the SUPEX group (3.8 -+ 2.74 to 11.2 - 4.02 minutes, 
respectively); similar results were obtained for MWT. At both completion and 6 months, 
there was a significant intergroup difference for CPT and MWT (p < 0.004) favoring 
SUPEX. For both groups, measures of  health perception based on the SF-36 demon- 
strated improvement (p < 0.002) in Physical Function Subscale, Bodily Pain Subscale, 
and Physical Composite Score. There were no between-group diffences on the subsets of  
the SF-36 at the three assessment intervals. 
Conclusions: Supervised exercise programs provide superior increased walking ability in 
the noninterventional therapy of  arterial claudication, and both supervised and home 
based exercise therapy result in improved SF-36 functional measures. The lack of  
intergroup differences in these measures may be a result of  the high degree of interaction 
with healthcare providers in the HOMEX group. Although a supervised program results 
in optimal walking benefits, a highly structured home-based program provides similar 
functional improvement and may be a satisfactory alternative for patients with lesser 
walking requirements. (J Vasc Surg 1997;25:312-9.) 
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Arterial claudication represents a major cause of  
morbidity in the elderly, with an annual incidence o f  
approximately 20 per 1000 in men and women over 
age 65. ~ This represents an estimated increase in 
disabling claudication of  more than 1 million symp- 
tomatic elderly patients every 2 years during the next 
50 years. 2 Although invasive interventions have re- 
cently been endorsed by an interdisciplinary commit- 
tee 3 for the therapy of  incapacitating claudication, 
exercise training has also proven to be effective in 
improving objective treadmill performance 2 and 
community-based walldng ability. 4 
Randomized trials that have reported improve- 
ment in exercise performance after training have used 
nonexercising control groups (i.e., patients in- 
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Table I. Patient attrition during course of study and reason for loss from study 
Reason Program onset During program 
Time of dropout 
At  posttest At  6-month follow-up 
Medica l  HOMEX - 0 HOMEX - 4 
SUPEX - 1 SUPEX - 0 
Refusal  HOMEX - 0 HOMEX - 1 
SUPEX-  1 SUPEX-  1 
Move/ job  HOMEX - 2 
SUPEX - 1 
D ied  
HOMEX - 2 
SUPEX-  3 
t - IOMEX - 0 HOMEX - 2 
SUPEX-  1 SUPEX-  1 
HOMEX - 0 
SUPEX - 2 
structed not to vary their usual activity) for compari- 
son. 4-7 Although this method has confirmed the pos- 
itive effects of exercise training, the role of direct 
supervision by trained personnel v rsus exercise in- 
struction to be performed in a home environment 
has not been well studied. 
Patients with intermittent claudication have a re- 
duced quality of life when measured by a variety of 
instruments. 8-12 Improvement after intervention 
(surgery or percutaneous angioplasty) has been sug- 
gested in nonrandomized studies, 8,~°,1s and exercise 
therapy has been demonstrated to improve measures 
of self-perceived health and function compared with 
nonexercising controls? 2 No study to date has iso- 
lated the effect of supervised exercise. 
We designed a carefully controlled study to eval- 
uate the benefits of a formal supervised exercise pro- 
gram compared with a ome-based exercise program 
with weeldy interventions in the form of lectures and 
exercise counseling. Our primary endpoints were ex- 
ercise performance, based on measured treadmill 
walking time, with secondary endpoints of measures 
of health perception. 
METHODS 
Patient population 
Patients between the ages of 50 and 75 with 
arterial claudication symptoms of greater than 
3-months' duration were recruited to the study. On 
recruitment, he patients underwent hemodynamic 
eligibility screening. Intermittent clandication from 
arterial insufficiency was established by resting ankle- 
brachial index (ABI) of less than 0.9 and a decrease in 
ankle pressure by 15 mm Hg or more after a standard 
exercise protocol (10 degree incline, 1.5 mph, 10 
minutes of exercise). Patients who did not meet hese 
hemodynamic criteria or had ischemic rest pain or 
tissue loss were excluded. Those patients who were 
unable to participate in an exercise program because of 
limitations of comorbid illness (arthritis, chronic ob- 
structive pulmonary disease, etc.) were also excluded. 
Because a significant number of patients with 
arterial claudication have associated coronary artery 
disease that may be silent within their limited daily 
activity, all patients who met he screening criteria 
outlined above underwent a graded exercise cardiac 
stress test (EST) by bicycle ergometry. 14Patients 
who exhibited no evidence of myocardial ischemia t 
exercise capacity on a submaximal (80% target heart 
rate) EST were admitted to the study. Patients with 
equivocal results were referred to their primary phy- 
sician for further evaluation. Ifdipyridamole myocar- 
dial perfusion imaging or an alternative cardiac 
screening method was performed and the level of 
exercise required by the exercise program was 
deemed safe, the patient was enrolled. Patients were 
excluded if exercise-related ischemia was discovered 
and thought o maize exercise therapy unsafe. The 
study was approved by the Miriam Hospital/Brown 
University Affiliated Hospitals Institutional Review 
Board, and informed consent was obtained from all 
eligible participants. 
Eighty-three patients were screened for participa- 
tion in the study. Twenty-three were deemed ineligible: 
eight failed cardiac screening, six had nonarterial c au- 
dication, four had comorbidities that precluded exer- 
cise, and five withdrew for scheduling and transporta- 
tion problems. To ensure hemodynamic comparability 
of groups, maximtun walking time to limiting claudica- 
tion (MWT) on the progressive treadinill exercise test 
at baseline was used to develop three strata, with ran- 
domization performed within each strata by computer 
matrix. Sixty patients were randomized with five more 
exduded at onset (Table I), equally divided between 
groups. The study population at entry included 29 men 
and 26 women with a mean age of 69.1 -+ 8.1 years. 
There was no difference in the demographics of the two 
groups at entry (Table II). 
Study design 
Patients with arterial claudication were random- 
ized to either a 12-week supervised exercise program 
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Table II. Demographic composition of study population 
Whole study (n = 55) SUPEX (n = 27) HOMEX (n = 28) 
Average Age 69.3 + 8.1 67.9 + 7.5 70.3 + 8.6 
Resting ABI[ 0.58 -- 0.13 0.57 + 0.15 0.59 + 0.12 
% Male 52.7 59.3 46.4 
% Previous MI 30.9 33.3 28.6 
% History CHF 9.1 7.4 10.7 
% Hypertension 61.8 70.4 53.6 
% Diabetes 34.5 29.6 39.3 
% Current smoker 23.6 25.9 21.4 
% History of smoking 82.6 90.9 75.0 
Average BMI 28.2 -+ 4.5 28.8 -+ 3.9 27,7 +- 4.9 
M/, Myocardial infarction; CHF, congestive heart failure; BMI, body mass index. 
(SUPEX) consisting of three i-hour sessions per 
week of treadmill and aerobic exercise with weekly 
lectures relating to peripheral vascular disease or to a 
home exercise group (HOMEX) who attended an 
identical lecture program and received weekly exer- 
cise instruction. Walldng performance including 
claudication pain time (CPT) and MWT was assessed 
at baseline, program completion, and 6 months. The 
Medical Outcomes Study 36-Item Short Form 
Health Survey (SF-36) was administered to assess 
effects on quality of life, social support, and self- 
reported activity levels. 
Supervised exercise (plus lecture) group. After 
baseline data collection, those patients assigned to 
the supervised exercise group had an individual exer- 
cise prescription established using the guidelines of 
the American College of Sports Medicine for cardiac 
and elderly patients? s Data from the bicycle stress 
test was used to determine resting heart rate, peak 
heart rate, peak blood pressure response to exercise, 
and metabolic equivalent of oxygen consumption 
(MET). Estimated energy expenditure in METs was 
calculated based on achieved workload.* Initial 
treadmill speed and grade was determined from entry 
treadmill testing data. The subjects then participated 
in a standardized 12-week supervised exercise pro- 
gram consisting of three exercise sessions per week of 
1 hour duration. The exercise prescription includes 
an aerobic component consisting of arm and leg 
ergometry and Air-Dyne cycling (Schwinn Bicycle 
Company, Chicago, Ill.) designed for cardiovascular 
training. Claudication-specific exercise periods were 
performed on the treadmills after the method of 
*MET = (V02 ml/min + body weight kg) + 3.5. 
V02 (ml/min) = (3.5 ml/kg/min x body weight kg) + (kg/ 
min × 2). 
kgm/min = kilogram meters/minute (power output) calculated 
from resistance and distance achieved with leg ergometer. 
V02 = Oxygen consumption. 
Feinberg et al? 6 In addition to recording resting 
heart rate and blood pressure at the initiation of each 
session, improvement in CPT was monitored to al- 
low for adjustment of the specific treadmill portion 
of the exercise program; the exercise prescription was 
recalculated at 2-week intervals for cardiovascular 
training. Adherence was assessed by attendance at 
exercise sessions, and subjects who missed a session 
were telephoned by the nurse specialist and encour- 
aged to attend make-up sessions. 
The exercise program also included weekly health 
education lectures addressing risk factors for athero- 
sclerosis and their modification as well as overviews 
of nutrition, exercise, and potential complications of 
atherosclerotic ardiovascular disease, specifically 
coveting warning signs and symptoms. 
Home exercise (plus lecture) group. Subjects 
in the HOMEX group attended a 12-week program 
of educational lectures identical to those attended by 
the SUPEX group. These were scheduled at a differ- 
ent time to avoid intergroup influence. HOMEX 
subjects were instructed to walk a minimum of three 
times a week at home to tolerance, for a period of 20 
to 40 minutes, in keeping with standard medical 
practice. Weekly exercise logs were maintained by 
the subjects and reviewed with the study nurses at 
the lecture sessions. Individual exercise counseling 
and review of home protocol was provided by the 
study nurse at each lecture session. This translated to 
approximately 1 V2 hours of direct contact weekly per 
patient in the HOMEX cohort. 
Measures 
Exercise and hemodynamic measures. Before 
randomization, all subjects underwent a graded pro- 
gressive maximal treadmill exercise test initiated at 1 
mph with a grade of 5%, increasing in speed and  
grade at 5-minute intervals through four stages to 
2.5 mph at 10% grade (equivalent of 6.4 METS). 
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Fig. 1. Values for CPT and MWT in HOMEX and SUPEX groups over course of study. 
*Difference from baseline, p < 0.001; **intergroup difference, p < 0.004. 
CPT and MWT were measured as specific endpoints. 
A "familiarization" test was administered at least 3 
days before the baseline test to minimize training 
effect and learning curve. The progressive treadmill 
test was repeated at 12 weeks (program completion) 
and 6 months. Resting anlde-brachial indexes and 
recovery times to self-reported pain relief and to 
return to baseline ABI were recorded at each interval 
as well. 
Quality of  life questionnaire. At pretreatment 
(baseline), posttreatment (12 weeks) and 6-month 
follow-up, all subjects were required to complete the 
SF-36, which was constructed for use in the Medical 
Outcomes Study and was designed for use in clinical 
practice and research. 17 The SF-36 assesses eight 
health concepts focusing on limitations in physical, 
social, and role activities, bodily pain, mental health, 
energy/fatigue, and general health perception. 
Statistical methods 
Data points at baseline, program completion (12 
weeks), and follow-up for the CPT and MWT as well 
as SF-36 were analyzed using repeated measures 
analysis of variance (ANOVA). Secondary analyses 
were conducted using paired t tests and one-way 
ANOVAs to determine the direction of significant 
results obtained from the repeat measures ANOVA. 
One-way ANOVAs with a Bonferroni correction 
were run to determine the baseline equivalence of 
the two groups, which had been stratified for the 
baseline walking time at randomization. All statistical 
analyses were conducted with the aid of SPSS for 
Windows, version 6.0. 
RESULTS 
Forty-seven of the initial 55 patients completed 
the 12-week program, 46 were available for testing at 
completion, and 38 for &month testing (three pro- 
vided questionnaire data only). Patients were lost to the 
study for medical reasons (10), refusal (7), death (2), 
and transportation a d job factors (3), evenly divided 
between HOMEX and SUPEX (Table I). No patients 
required intervention for lower extremity ischemia dur- 
ing the study or in the follow-up period. 
At baseline, both groups were matched by perfor- 
mance on the progressive treadmill test. The average 
CPT was 3.7 + 2.71 minutes, corresponding to 
88 m, with no patient able to walk more than 10.8 
minutes (350 m). The average MWT was 5.4 + 3.00 
minutes, corresponding to 145 m of ambulation, 
with no patient able to walk beyond 14.8 minutes 
(585 m). 
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Table II I .  Scores for SF-36 of SUPEX and HOMEX groups at baseline, program completion, and 
6-month follow-up 
Baseline Program completion 6-month follow-up 
S UPEX HOMEX S UPEX HOMEX S UPEX HOMEX 
Physical function 43 -+ 17.7 41 -- 20.8 52 -+ 22.2* 53 ± 24.4* 56 -+ 14.4" 54 ± 23.5* 
Role-physical function 45 -+ 42.2 30 ± 34.7 44 ± 42.2 49 ± 41.6 49 -+ 39.7 45 -- 41.0 
Pain index 53 ± 20.8 51 ± 20.6 64 -+ 23.6* 61 ± 21.6" 62 _+ 20.6* 64 ± 19.3" 
General health 64 -+ 18.9 60 ± 23.0 65 _+ 16.8 62 +_ 22.8 64 _+ 13.8 64 _+ 22.5 
Vitality score 52 ± 19.9 46 ± 18.9 53 _+ 16.9 57 ± 15.9 54 _+ 17.9 55 ± 19.5 
Social function 81 _+ 22.8 80 ± 21.1 87 -+ 15.2 82 -- 17.6 81 ± 18.3 88 -+ 14.6 
Role-emotional health 71 _+ 36.6 76 ± 33.8 72 -+ 36.3 74 +_ 33.3 70 _+ 36.0 77 +- 32.6 
Mental health 72 -+ 18.8 70 ± 18.3 74 -+ 14.8 77 ± 13.6 72 _+ 16.1 78 -+ 13.8 
Standard physical component 35 -+ 7.1 33 ± 9.4 38 -+ 8.3* 38 ± 12.0" 39 -+ 8.6* 38 ± 11.1" 
Standard mental component 53 ± 9.6 53 ± 9.0 53 ± 8.3 54 ± 8.2 51 -+ 10.2 55 ± 7.3 
Walk 1+ miles 1.2 -+ 0.5 1.2 ± 0.5 1.3 -+ 0.5* 1.5 ± 0.7* 1.3 -+ 0.5* 1.5 -+ 0.6* 
Walk many blocks 1.26 ± 0.5 1.39 ± 0.6 1.75 ± 0.7* 1.96 ± 0.8* 1.72 _+ 0.7* 1.75 ± 0.8* 
Walk 1 block 1.70 -+ 0.7 1.86 -+ 0.7 2.04 -+ 0.9* 2.52 -+ 0.7* 2.44 ± 0.5* 2.45 -+ 0.8* 
There was no statistically significant intergroup difference atany interval. 
*Difference from baseline, p < 0.01. 
Improvement in CPT and MWT was seen in both 
groups (Fig. 1) at completion of the 12-week study, 
which was sustained at 6-month follow-up (p < 
0.001). The HOMEX group had improvement in
both CPT and MWT of 131% and 70% respectively 
versus 337% and 207% for the SUPEX group (p < 
0.004). The actual improvement in the SUPEX 
group is underestimated as a result of three patients 
walking beyond the fourth stage (20 minutes) of the 
graded exercise test for both CPT and MWT. In the 
HOMEX group one patient walked beyond 20 min- 
utes for MWT only. Time to return to baseline ABI 
and time to self-reported pain relief was no different 
at baseline between groups and demonstrated no 
significant change at either posttesting or 6-month 
follow-up. 
There were no differences at baseline between 
treatment groups on the eight standard subscales of 
Physical Function, Role-Physical Function, Pain In- 
dex, General Health, Vitality Score, Social Function, 
Role-Emotional, or Mental Health (Table III). Sim- 
ilarly, composite scores of Physical and Mental Com- 
ponents and the three individual walking items were 
no different at baseline. 
At posttesting, scores on Physical Function, 
Bodily Pain, and Physical Composite, as well as walk- 
ing 1 + miles, many blocks, and 1 block improved for 
both SUPEX and HOMEX (p < 0.01), with no 
intergroup differences. This improvement was un- 
changed at follow up for both groups (Table III). 
DISCUSSION 
Exercise therapy for intermittent claudication is
effective in the relief of debilitating symptoms, with 
improvements in claudication pain distance of 179% 
and in distance to maximum claudication pain of 
122% found in a recent meta-analysis of21 studies. 2 
Of these studies, 11 were performed at an on-site 
facility supervised by trained personnel, two were 
solely home-based, and eight combined on-site and 
home-based programs. Although the authors identi- 
fied several components of exercise programs that 
correlated with increasing improvement in walking 
ability, they noted no difference in outcome between 
on-site and combined programs. The majority of 
these studies, however, were nonrandomized or un- 
controlled, and the three randomized controlled 
studies included in the analysis used nonexercising 
controls. 
Our results support the superiority of walking 
distance improvement in patients who participate in 
a supervised exercise program. The group improve- 
ment for SUPEX is underestimated because of limi- 
tations at the upper end of the graded treadmill 
exercise test, but conservatively translates into an 
improvement of 190 additional meters of pain-free 
treadmill walking and 290 meters of maximal tread- 
mill walking over the HOMEX group at &month 
follow-up. Although the possibility of some treadmill 
training effect exists in the SUPEX group, the 
HOMEX group walked well into the third stage of 
the progressive test at completion and follow-up. A 
previous tudy 18 found improvement in walking on a 
less-rigorous static treadmill test (between 3.2 and 
5.4 km/h  at no grade) underestimated free walking 
distance improvement by 50%, suggesting an im- 
provement in clinical walking ability for the SUPEX 
group in excess of four blocks over baseline. We have 
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added an additional stage to our graded progressive 
treadmill test to avoid the truncation of walking 
improvement in future studies. 
The baseline scores on the SF-36 are significantly 
depressed in Physical Function and General Health 
compared with patients without chronic conditions 
in the Medical Outcomes Study, rs and are compara- 
ble with patieiats with congestive heart failure, myo- 
cardial infarction, and chronic lung problems. Re- 
sponses to Mental Health and Social Function 
questions were less affected, in keeping with the 
findings in other populations with chronic medical 
conditions. Our patients' scores were comparable 
with other patients with peripheral arterial disease 
who undergo elective surgery. 11 The improvement 
with time in the scores of both the HOMEX and 
SUPEX groups are consistent with the findings of 
Regensteiner et al.,12 who found improvement in 
physical functioning score in patients who under- 
went 24 weeks of supervised treadmill exercise 
but no significant change in their control (initially 
nonexercising) or strength training group. A retro- 
spective, cross-sectional study of patents having un- 
dergone invasive (i.e., bypass or endoluminal revas- 
cularization) or noninvasive therapy suggested 
improvement in patients' perception of their health 
and well-being as measured with the SF-36 when 
treated invasively, but not when managed noninva- 
sively. 13 There was no exercise therapy arm in this 
retrospective study, with their noninvasively man- 
aged patients representing more traditional ap- 
proaches to nonoperative management. 
The lack of differences between the HOMEX and 
SUPEX groups in improvement in quality of life 
measures are not surprising given the rigorous nature 
of our control group. To replicate a clinical program 
of exercise therapy for claudication and to control 
solely for the effects of exercise supervision, we ex- 
posed the HOMEX group to the same series of 
weekly lectures as our SUPEX group. To monitor 
their degree of home exercise, they maintained 
weekly activity logs that were reviewed at each lec- 
ture session with the program nurse. They also were 
afforded the opportunity to have individual exercise 
counseling with the nurse at these sessions to answer 
questions regarding their activity and progress. 
Other than the absence of direct, monitored exercise 
supervision, the groups received far more interven- 
tion than is customarily available to the patient who 
goes to his primary physician or surgeon with com- 
plaints of intermittent claudication. 
Optimal methods for assessing quality of life in 
patients with peripheral arterial disease have not been 
established. The SF-36 has generally been adminis- 
tered to large patient samples (more than 200); even 
in such samples the standard eviations for the scores 
are high. 19,2° In addition to the SF-36, the Notting- 
ham Health Profile, 9 the EuroQuol, 1° and the Mc- 
Master Health Index Questionnaire 21 have been 
used to assess quality of life and consistently demon- 
strate impairment in quality of life measures in pa- 
tients with intermittent claudication when compared 
with healthy, age-matched controls. The confound- 
ing effects of the many comorbidities that affect pa- 
tients with intermittent claudication are difficult to 
control for and may account for the lack of change 
after an exercise program in parameters not directly 
related to pain and physical function. 
As optimal means for treatment of arterial claudi- 
cation are sought and with an increasing population 
of patients at risk, specifics of design of programs for 
the noninterventional therapy of this disease become 
increasingly important. Third-party carriers and 
managed care providers do not uniformly provide 
reimbursement for exercise therapy of claudication, 
despite agrowing body of evidence documenting the 
efficacy of these programs. Our study confirms upe- 
rior improvement in walking ability as measured with 
objective treadmill testing with a formal, supervised 
exercise program over an intensive home-based pro- 
gram. The objective improvement in quality of life 
with both exercise protocols may be a result of the 
intensive support from the nurses and therapists su- 
pervising the program. For those patients who do 
not require maximum freedom from claudication to 
perform their daily activities, a highly structured, 
intensive home-based program may be a satisfactory 
alternative. A supervised program results in optimal 
walking improvement and should be compared with 
other interventions (angioplasty, surgery) for both 
walking and quality of life improvement. 
REFERENCES 
1. Kannel WB, McGee DL. Update on some epidemiologic 
features on intermittent cladication: the Framingham Study. J
Am Geriatr Soc 1985;33:13-8. 
2. Gardner AW, Poehlman ET. Exercise rehabilitation programs 
for the treatment of claudication pain: a meta-analysis. JAMA 
1995;274:975-80. 
3. Pentecost M]', Criqui MH, Dorros G, Goldstone J, Johnston 
KVV, Martin EC, et ai. Guidelines for peripheral percutaneous 
transluminal ngioplasty of the abdominal aorta and lower 
extremity vessels. Circulation 1994;89:511-31. 
4. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass 
EP. Benefit of exercise conditioning for patients with periph- 
eral arterial disease. Circulation 1990;81:602-9. 
5. Dahloff AG, Bjorntorp P, Holm J, Schersten T. Metabolic 
activity of skeletal muscle in patients with peripheral arterial 
JOURNAL OF VASCULAR SURGERY 
318 Patterson et al. February 1997 
insufficiency: effect of physical training. Eur J Clin Invest. 
1974;4:9-i5. 
6. Holm J, Dahllof AG, Bjorntorp P, Schersten T. E zyme 
studies in muscles of patients with intermittent claudication: 
effect of training. Scand J Clin Lab Invest. 1973;31(suppl 
128);201-5. 
7. Larsen OA, Lassen NA. Effect of daily muscular exercise 
in patients with intermittent claudication. Lancet 1966;2: 
1093-6. 
8. Bosch JL, Hunink MGM, Tetteroo E. Improvement i  qual- 
ity of life after revascularization for aortoiliac arterial disease. 
Presented at Society for Medical Decision Making, Tempe, 
Ariz., Oct. 1995. 
9. Khaira HS, Hanger R, Shearman CP. Quality of life in pa- 
tients with intermittent claudication. Eur J Vase Endovasc 
Surg 1996;1 h65-9. 
10. Cook TA, O'Regan M, Galland RB. Quality of life following 
percutaneous transhiminal angioplasty for clandication. Eur J 
Vase Endovasc Surg 1996;lh191-4. 
11. Mangione CM, Donaldson MC, Cook EF, Whittemore AD, 
Lee TH, Mannick JA. Perception of change in health status 
among patients undergoing elective vascular surgery. In: 
Greenhalgh RM, Fowkes FGR, editors. Trials and tribula- 
tions of vascular surgery. London: W.B. Saunders, 1996:1-5. 
12. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training 
improves functional status in patients with peripheral arterial 
disease. J Vase Surg 1996;23:104-15. 
13. Reifler DR, Eeinglass J, Slavensky R,Martin GJ, Manheim L, 
McCarthy WJ. Functional outcomes for patients with inter- 
mittent claudication: bypass surgery versus angioplasty versus 
noninvasive management. J Vase Med Biol 1994;5:203-1 I. 
14. Ellestad MH, Blomqvist CG, Naughton JP. Standards for 
adult exercise testing laboratories. American Heart Associa- 
tion Subcommittee onRehabilitation Target Activity Group. 
Circulation 1979;59:421A. 
15. Exercise testing and prescription for children, the elderly, and 
pregnancy. In: Kenney WL, Humphrey RH, Bryant CX, et 
al., editors. American College of Sports Medicine Guidelines 
for Exercise Testing and Prescription. 5th ed. Philadelphia: 
Williams & Wdldns, 1995:220-40. 
16. Feinberg RL, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle 
RG, Parent EN III, Patterson RB. The ischemic window: a 
method for the objective quantitation of the training effect in 
exercise therapy for intermittent claudication. J Vase Surg 
1992;16:244-50. 
17. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, 
Berry SD, et al. Functional status and well-being of patients 
with chronic conditions: results from the medical outcomes 
study. JAMA 1989;262:907-13. 
18. Carter SA, Hamel Ell, Paterson JM, Snow CJ, Mymin D. 
Walking ability and ankle systolic pressures: observations in 
patients with intermittent claudication in a short-term walk- 
ing exercise program. J Vase Surg 1989;10:642-9. 
19. Stewart AL, Hays RD, Ware JE. The MOS Short-Form Gen- 
eral Health Survey: reliability and validity in a patient popula- 
tion. Med Care 1988;27:724-35. 
20. McHorney CA, Kosinski M, Ware JE. Comparisons of the 
costs and quality of n rms for the SF-36 health survey col- 
lected b mail versus telephone interview: results form a na- 
tional survey. Med Care 1994;32:551-67. 
21. Barletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Bre- 
vetti G. Quality of life in patients with intermittent cla dica- 
tion: relationship with laboratory exercise performance. Vas- 
cular Medicine 1996;1:3-7. 
Submitted June 14, 1996; accepted Sep. 27, I996. 
DISCUSSION 
Dr. Walter J. McCarthy I I I  (Chicago, Ill.). The 
authors are to be congratulated on the design of this 
carefully randomized prospective trial. They randomized 
55 patients ,echo were selected to be the most likely to 
benefit from an exercise program, that is, patients younger 
than 75 years of age and without complicating comorbidi- 
ties that would interfere with an exercise program, such as 
arthritis, chronic obstructive pulmonary disease, or coro- 
nary disease. 
They defined patients who had claudication with the 
most sophisticated evaluation, using an ABI decrease of 
0.15 with treadmill exercise testing. Finally, their end 
points were based on graded, progressive treadmill testing, 
which is generally thought to be the optimal way to accom- 
plish this testing. The survey instruments included the 
MOS SF-36, which has very wide recognition and accep- 
tance, and other instruments hat are widely accepted. In 
fact, this paper really is a showcase for the facile use of 
survey instruments. 
The home exercise group exercised at home and the 
supervised group with exercise equipment, including 
treadmills. The results were gratifying in both groups, with 
a roughly 170% increase at home and 280% increase in the 
supervised group. And these differences were significant 
between groups. 
This brings me to my questions. I think the most 
serious criticism of this manuscript will stem from the fairly 
well-established observation that people learn to walk on 
treadmills by using them. Thus your supervised group, 
having exercised with treadmills, have a marked advantage 
that possibly explains their superior performance. Notice 
that their self-reported physical function was about equal. I 
wonder whether you could address how significant you 
think that experience on the treadmill was. 
Second, tell us how many patients had iliac disease as 
compared with superficial femoral-based disease. And did 
the level of the disease or the initial ABI impact on their 
improvement potential? 
Finally, tell us how this information applies to the more 
general cohort of patients with claudication that we see, 
including those who are older, patients that are in their 
80s, for example, and those with multiple comorbidities. 
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Dr. Robert B. Patterson. Thank you, Dr. McCarthy 
for your comments. With respect to treadmill training, we 
recognize that people do learn to walk on a treadmill more 
efficiently. We attempted to control for that by having 
every patient undergo some treadmill testing and training 
before the baseline treadmill test. 
In terms of the breakdown between iliac and femo- 
ropopliteal disease, I am afraid I cannot give those data to 
yon now. We are going to look at disease location as a 
factor in a larger group to include patients from a clinical 
program. In this study population there was no difference 
in response with regard to their resting ABI. In fact, what 
seems to be the greatest difference in response issomething 
that my behavioral medicine colleagues are investigating 
now, that people have different approaches to exercise and 
attitudes toward their health. It may be possible to identify 
people who would be more likely to benefit from a pro- 
gram such as this. 
This brings me to the patient application portion f 
your question. We have found, particularly in our clinical 
program, that exercise therapy is applicable to a wide vari- 
ety of patients. We have successfully treated many octoge- 
narians, as well as patients with renal failure and significant 
heart disease. The truly problematic patients are those who 
would not benefit from iliac artery angioplasty or surgery, 
the patients with debilitating arthritis or chronic obstruc- 
tive pulmonary disease, who indeed clandicate, but when 
they are exercised it is frequently their comorbid illness that 
is limiting in their daily activities. 
Dr. Bruce M. Elliott (Charleston, SC). That was 
simply an elegant study, and I thoroughly enjoyed it. We 
all have observed that an important component of im- 
provement on clandication is the cessation of smoking. I 
was wondering whether perhaps you had a large number of 
patients who were active smokers at entry, what the success 
rate in quitting was, and was there a difference between 
those who were closely supervised versus those who were at 
home? 
Dr. Patterson. Some of the original work that is pre- 
sented on this is Dr. Williams' work, where a large number 
of patients who entered their program who were smokers 
who were successful in quitting and bad a very durable 
result. Actually, only 25% of our patients were currently 
smoking, and we did not address moldng cessation as an 
issue for them. Most of our patients had a history of 
smoking, but many had already quit when they came to us. 
Dr. Roger Greenhalgh (London, United Kingdom). 
I liked this tudy for various reasons. It is of great impor- 
tance that we determine the optimal exercise program for 
patients, if for no other reason that we need to combine 
other treatments with exercise, against exercise alone, to 
see whether these other treatments have any benefit. And 
so we must first know hat is the optimal exercise program. 
There has been difficulty on both sides of the Atlantic 
in determining anoptimal end point, and you have quoted 
claudication time and walking time. There has to be some 
caution in regarding these as objective, because, indeed, 
they are not truly objective. They relate to the moment at 
which those patients decide they are going to stop walking 
or when the claudication occurs. So there is a subjective 
element to it. Indeed, there is poor repeatability for any 
patient of the claudication and walking time. Our group 
puts the walking time range at something like 11/2 minutes. 
Therefore, if the variation is11/2 minutes, and the end point 
is not truly objective, then a little caution is required in 
determining this best exercise program. 
Dr. Patterson. Thank you, Dr. Greenhalgh. The use 
of a progressive treadmill test eems to help in stratifying 
these patients more carefully. And I agree with you, it is 
more that it is an easily measured end point than one that is
truly objective. It is based on the subjective response of the 
patient. 
Dr. Stefan A. Carter (Winnipeg, Manitoba, Canada). 
Similar results were presented at this meeting that also 
showed, as you did, that a supervised treadmill w~dking 
program was superior to a home program. In terms of 
accessibility and costs, I would like to make a comment 
that it is possible to train people not on a treadmill and not 
in the hospital but in a rehabilitation facility or even in 
shopping malls if they do it consistently. That is what we 
have done in Winnipeg, where we have trained people in a 
rehabilitation facility and they achieved walldng ability of
walking more than a mile, in more than 80% of patients, at 
a speed of 2 to 3 miles an hour. In terms of need in the 
community, this is obviously excellent and much as what 
you have indicated. This may be possible for many people. 
Also, we see people in the lab, who are referred because 
somebody cannot feel their pulses, who have grossly ab- 
normal ABIs and who can walk without limitations up to a 
mile. And there is no reason to doubt it because we have 
the same kind of patients in our exercise program. I agree 
that level of disease does not influence it; people with 
bilateral disease and with ABIs at 0.5 or less can do well. 
I have one question. You indicated that at entry you 
are taking people with duration of symptoms, I believe, of 
3 months or more. I believe that there are data that show 
that patients can improve their claudication distance spon- 
taneously for up to a year or more, and in some of them 
blood flow after eactive hyperemia or even their anlde- 
brachial index do improve somewhat. So I wonder whether 
there is a difference between people with short and longer 
duration of symptoms at entry. 
Dr. Patterson. Thank you, Dr. Carter. I do not have 
the exact numbers with me, but most of our patients had 
significantly onger duration of symptoms than 3 months. 
Most of them had had claudication for several years. We 
used three months as an arbitrary cutoff to avoid having 
patients who had the recent onset of symptoms, many of 
whom get somewhat better very quickly. In addition, fre- 
quently patients that were referred to this study were pa- 
tients who had undergone angioplasty or surgery in the 
past that had failed. If it was several years go, we were 
willing to accept hem into the study, but certainly no one 
was accepted who had undergone any recent interventions. 
